202 related articles for article (PubMed ID: 35924839)
1. Differential Impact of the
Yu MC; Hung CS; Huang CK; Wang CH; Liang YC; Lin JC
Microbiol Spectr; 2022 Aug; 10(4):e0075422. PubMed ID: 35924839
[TBL] [Abstract][Full Text] [Related]
2. Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.
Jamieson FB; Guthrie JL; Neemuchwala A; Lastovetska O; Melano RG; Mehaffy C
J Clin Microbiol; 2014 Jun; 52(6):2157-62. PubMed ID: 24740074
[TBL] [Abstract][Full Text] [Related]
3. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
[No Abstract] [Full Text] [Related]
4. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Tan Y; Hu Z; Zhao Y; Cai X; Luo C; Zou C; Liu X
J Clin Microbiol; 2012 Jan; 50(1):81-5. PubMed ID: 22075601
[TBL] [Abstract][Full Text] [Related]
5. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
[TBL] [Abstract][Full Text] [Related]
6. Low-Level Rifampin Resistance and
Shea J; Halse TA; Kohlerschmidt D; Lapierre P; Modestil HA; Kearns CH; Dworkin FF; Rakeman JL; Escuyer V; Musser KA
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 32999007
[TBL] [Abstract][Full Text] [Related]
7. Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan.
Qadir M; Tahseen S; McHugh TD; Hussain A; Masood F; Ahmed N; Faryal R
J Infect Chemother; 2021 Nov; 27(11):1578-1583. PubMed ID: 34244055
[TBL] [Abstract][Full Text] [Related]
8. Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis.
Li J; Yang T; Hong C; Yang Z; Wu L; Gao Q; Yang H; Tan W
Microbiol Spectr; 2022 Jun; 10(3):e0271421. PubMed ID: 35658579
[TBL] [Abstract][Full Text] [Related]
9. Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant
He G; Zheng Q; Wu J; Wu L; Geng Z; Jiang G; Huang H; Jiang X; Yu X
Microbiol Spectr; 2024 Jun; 12(6):e0385923. PubMed ID: 38738892
[TBL] [Abstract][Full Text] [Related]
10. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
[TBL] [Abstract][Full Text] [Related]
12. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
[TBL] [Abstract][Full Text] [Related]
13.
Zeng MC; Jia QJ; Tang LM
J Int Med Res; 2021 Mar; 49(3):300060521997596. PubMed ID: 33715498
[TBL] [Abstract][Full Text] [Related]
14. Automatic Identification of Individual
Cao Y; Parmar H; Simmons AM; Kale D; Tong K; Lieu D; Persing D; Kwiatkowski R; Alland D; Chakravorty S
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31533985
[TBL] [Abstract][Full Text] [Related]
15. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
Farhat MR; Sixsmith J; Calderon R; Hicks ND; Fortune SM; Murray M
J Antimicrob Chemother; 2019 Jun; 74(6):1477-1483. PubMed ID: 30793747
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
Mboowa G; Namaganda C; Ssengooba W
BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
[TBL] [Abstract][Full Text] [Related]
19. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
20. The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.
Sirgel FA; Warren RM; Böttger EC; Klopper M; Victor TC; van Helden PD
PLoS One; 2013; 8(3):e59414. PubMed ID: 23527189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
